ESC Professional Premium Access

Coronary artery disease - Pharmacotherapy 2

Event: ESC Congress 2022
Topic: Pharmacotherapy
Session type: Moderated ePosters
Date: 28 August 2022
Time: 08:15 - 09:00

Congress Session

5 presentations in this session

P2Y12 inhibitors monotherapy in patients undergoing complex vs. non-complex percutaneous coronary intervention: a meta-analysis of randomized trials

Speaker: Doctor A. Oliva (Milan, IT)

Liposomal docosahexaenoic acid halts atherosclerosis progression

Speaker: Miss S. Chong (Singapore, SG)

The effect of vitamin k2 supplementation on coronary artery disease in a randomized multicenter trial

Speaker: Doctor S. Hasific (Odense, DK)

Effects of CYP3A4*22 carrier and CYP3A5 expressor status on clinical outcome in patients treated with ticagrelor for acute coronary syndrome

Speaker: Doctor J. Azzahhafi (Nieuwegein, NL)

Comparison of the Efficacy and Safety between different Oral P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome: a Systematic Review and Meta-Analysis

Speaker: Doctor A. Lepone (Pisa, IT)

5 speakers from this session

Doctor Angelo Oliva

Humanitas Research Hospital, Milan (Italy)
0 follower

Miss Suet Yen Chong

Cardiovascular Research Institute, Singapore (Singapore)
0 follower

Doctor Selma Hasific

Odense University Hospital, Odense (Denmark)
0 follower

Doctor Jaouad Azzahhafi

St Antonius Hospital, Nieuwegein (Netherlands (The))
0 follower

Doctor Attilio Lepone

Azienda Ospedaliero Universitaria Pisana, Pisa (Italy)
0 follower

This platform is supported by

logo Novo Nordisk